Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Projet de cuivre-or Chibougamau, Canada FAITS SAILLANTS : Les forages intercalaires à Golden Eye ont recoupé des intervalles aurifères à haute teneur atteignant jusqu’à 105,5 g/t ÉqAu sur 1,0 m,...
-
Chibougamau Copper-Gold Project, Canada HIGHLIGHTS: Infill drilling at Golden Eye has returned high-grade gold intervals of up to 105.5g/t AuEq over 1.0m, alongside copper grades of up to 11.9% Cu...
-
Minneapolis, MN, April 15, 2026 (GLOBE NEWSWIRE) -- Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // Purpose-driven digital payment platform, Sezzle, will release its first quarter 2026 results...
-
BRISBANE, Australia, April 15, 2026 (GLOBE NEWSWIRE) -- North American lithium producer Elevra Lithium Limited (ASX:ELV; NASDAQ:ELVR; OTC:SYAXF) (“Elevra” or “Company”) advises that the Company’s...
-
AVITA founder Fiona Wood receives ABA Lifetime Achievement Award for pioneering burn care and developing RECELL Spray-On Skin technology
-
SYDNEY, AUSTRALIA, April 15, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company targeting cancer and autoimmune...
-
MELBOURNE, Australia and SAN FRANCISCO, April 15, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to...
-
MELBOURNE, Australia, April 15, 2026 (GLOBE NEWSWIRE) -- CLINUVEL’s innovative photomedicine and vitiligo programs featured extensively at the recent American Academy of Dermatology (AAD) Annual...
-
NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has acquired...
-
MELBOURNE, Australia and INDIANAPOLIS, April 15, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient has been dosed with...